Filters included 5 of 26 total posts
AIROGS Challenge Report: AI models can be used for glaucoma screening, but do they know when they cannot?
The rationale behind the Artificial Intelligence for RObust Glaucoma Screening (AIROGS) Challenge, an overview of its results and our experiences with Grand Challenge's new Type 2 challenges.
Can AI predict breast cancer recurrence via automated quantification of tumor-infiltrating lymphocytes?
TIGER is the first challenge on fully automated assessment of tumor-infiltrating lymphocytes (TILs) in hematoxylin and eosin (H&E) breast cancer histopathology slides. With TIGER, we released a training set of 390 whole-slide images and a total award of $13,000 in AWS Credits, which will be awarded to the winning teams. Together with its participants, we aim to find the best AI-based solutions for automating the assessment of the TILs and produce a “TILs score” that can predict the recurrence of breast cancer.
Last week, we opened STOIC2021: A COVID-19 AI challenge with 10,000 CT scans. Together with its participants, we aim to find the best solution for predicting who will develop severe COVID-19 from a chest CT scan. We will make the final solution easily accessible for everyone. In total, $20,000 in AWS Credits will be awarded to the winning teams.